• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA warns on ERCP endoscope, CRE “superbug” link

FDA warns on ERCP endoscope, CRE “superbug” link

February 20, 2015 By Val Kennedy

FDA warns on pediatric use of bone growth proteins

The FDA is warning that ERCP endoscopes may allow for the transmission of certain drug-resistant “superbugs,” even if the devices are properly cleaned.

The advisory was issued in the wake of news that contaminated endoscopes are suspected of causing a deadly outbreak of the superbug CRE, or carbapenem-resistant enterobacteriaceae (CRE), among patients at the UCLA Ronald Reagan Medical Center in Los Angeles.

According to the LA Times, UCLA has confirmed that seven patients who underwent procedures with the scopes were later found to have contracted CRE. Two of the patients died. The hospital revealed Wednesday it is offering screening tests to 179 other patients who have undergone similar procedures since October.

The devices, also known as a duodenoscopes, are long, illuminated tubes that are inserted into the mouth and maneuvered through the esophagus to the small intestines. The scopes, which often feature tiny cameras, are used for a variety of procedures involving the intestines, pancreas, gallbladder, liver and stomach.

According to the FDA, the devices feature crevices that can harbor pathogens, such as CRE and E. coli, even after rigorous cleaning and disinfection. The agency is advising healthcare professionals to alert patients to signs of possible infection and to consider taking the scopes out of service until they are confirmed to be pathogen-free.

The devices are marketed in the U.S. by Fujifilm, Olympus and Pentax, the agency said.

From January 2013 to December 2014, the FDA received reports that approximately 135 patients may have been exposed to dangerous pathogens through duodenoscope procedures. The agency added the actual number of patients at risk could be higher.

The FDA estimates that roughly 500,000 procedures are performed annually using ERCP endoscopes.


Filed Under: Endoscopic, Food & Drug Administration (FDA), News Well Tagged With: Fujifilm, Olympus, Patient Safety, Pentax

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy